Remove Bioinformatics Remove Information Remove Research
article thumbnail

Terra is now generally available on Microsoft Azure

Broad Institute

Through Terra, researchers can gain access to genomics and other data modalities used for biomedical research, as well as run state-of-the-art workflows developed by Broad and wider bioinformatics community. Expanding Terra onto Azure enhances support for enterprises and data scientists worldwide.

article thumbnail

Genomic score predicts patients' progression to multiple myeloma

Broad Institute

In the future, the MM-like score could be used in clinical practice to inform decisions about early intervention. This study brings us closer to more personalized care for patients with a precursor stage of cancer and could better inform early intervention strategies in the future. The study was published in Nature Genetics.

DNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

Multimodality however can detect and connect trends (and in future generate content) across different modalities and therefore allows for better interpretability, which builds trust between regulators, researchers and industry stakeholders. This approach limits the transformative potential of the technology.

Drugs 64
article thumbnail

Case study: NCI’s Molecular Targets Platform

The Open Targets Blog

 To address this disparity, the USA’s Research to Accelerate Cures and Equity (RACE) for Children Act as of 2020 requires any company designing a clinical trial for an antineoplastic therapy to include a pediatric trial component if the gene target is on the FDA’s Pediatric Molecular Target Lists (PMTL).  By

article thumbnail

Therapeutic Oligos 2025 Keynote Speakers Announced

Elrig

There will also be a poster award for early-career professionals recognising the research that the next generation of scientists bring to drug discovery. There, he worked with the GENCODE consortium to establish foundational lncRNA gene annotations, which are considered a standard reference in the field.

RNA 59
article thumbnail

Scientific workflow for hypothesis testing in drug discovery: Part 1

Drug Target Review

In drug discovery and biological research, the scientists workflow often follows a structured and iterative approach to ensure accuracy, reproducibility and scientific integrity. At the heart of any research is the scientific question. The next critical step is the sanity check phase, where the integrity of the dataset is assessed.

RNA 52
article thumbnail

Biochemical assays and deep cyclic inhibition in cancer treatment

Drug Target Review

Omics data, including pharmacogenomics data from 3D-TGAs, provide us with unique information about the molecular mechanisms of disease biology and drug response. Importantly, transcriptomics information shows that certain aspects of a disease change the gene expression profile.